Cargando…
A Feasibility Study of AlzLife 40 Hz Sensory Therapy in Patients with MCI and Early AD
Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI) are debilitating diseases that affect millions of individuals and have notoriously limited treatment options. One emerging therapy, non-invasive 40 Hz sensory therapy delivered through light and sound has previously shown promise in improv...
Autores principales: | McNett, Sienna D., Vyshedskiy, Andrey, Savchenko, Andrei, Durakovic, Danijel, Heredia, George, Cahn, Rael, Kogan, Mikhail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379682/ https://www.ncbi.nlm.nih.gov/pubmed/37510481 http://dx.doi.org/10.3390/healthcare11142040 |
Ejemplares similares
-
Boston cognitive assessment (BOCA) — a comprehensive self-administered smartphone- and computer-based at-home test for longitudinal tracking of cognitive performance
por: Vyshedskiy, Andrey, et al.
Publicado: (2022) -
AlzPharm: integration of neurodegeneration data using RDF
por: Lam, Hugo YK, et al.
Publicado: (2007) -
The paradox of opposite directions of gene expressions in MCI and AD suggests possible therapy to prevent progression of MCI to AD
por: Fessel, Jeffrey
Publicado: (2020) -
An MRI-Derived Definition of MCI-to-AD Conversion for Long-Term, Automatic Prognosis of MCI Patients
por: Aksu, Yaman, et al.
Publicado: (2011) -
AlzPathway: a comprehensive map of signaling pathways of Alzheimer’s disease
por: Mizuno, Satoshi, et al.
Publicado: (2012)